The Impact of Medical Inflation on Future Medical Cost Estimates in Personal Injury Claims

Disclaimer: This article provides general information only and does not constitute legal advice. You should consult a qualified solicitor for advice specific to your circumstances. 本文不構成法律建議。涉及個人案件請諮詢持牌律師。

The Hong Kong Hospital Authority’s Annual Plan for 2025-2026 projects a recurrent expenditure increase of 8.7% to HK$98.7 billion, driven largely by rising staff costs and medical supplies inflation. For a plaintiff in a personal injury claim, this single statistic signals a fundamental shift in how the court should assess future medical expenses. The common practice of applying a flat, inflation-free multiplier to current medical cost estimates is no longer tenable. A failure to account for medical-specific inflation can under-compensate a claimant by hundreds of thousands of dollars over a lifetime of care. The Court of Final Appeal in Chan Pak Ting v. HKSAR (2007) 10 HKCFAR 29 established that damages must place the plaintiff in the same position as before the injury, so far as money can. If the cost of future care is set to rise faster than general prices, the award must reflect that reality. This article explains the legal framework, the actuarial method, and the practical steps to ensure your claim accounts for medical inflation.

The Legal Basis for Future Medical Cost Awards in Hong Kong

The Principle of Full Restitution

The governing principle in Hong Kong tort law is restitutio in integrum. The Court of Appeal in Lau Tak Wo v. HKSAR (2004) 7 HKCFAR 587 confirmed that damages are compensatory, not punitive. For future medical costs, this means the award must cover the actual, anticipated expenditure over the plaintiff’s remaining life, discounted to present value.

The court does not award a lump sum equal to the total projected cost. Instead, it applies a discount for early receipt, typically using the “Ogden Tables” or similar actuarial tools. The discount rate in Hong Kong is not fixed by statute, but courts have historically used a rate of 2.5% to 3% per annum, derived from yields on Hong Kong government bonds. This rate assumes that the invested lump sum will grow at a real rate of return after inflation. However, the critical flaw in this approach is that it uses a general inflation rate, not a medical-specific inflation rate.

The Distinction Between General Inflation and Medical Inflation

General inflation in Hong Kong, as measured by the Composite Consumer Price Index (CCPI), averaged 1.9% per annum from 2019 to 2024. Medical inflation, as tracked by the Hospital Authority’s recurrent expenditure per capita, has averaged 4.5% per annum over the same period. The gap is not trivial. Medical inflation is driven by factors that do not affect general prices: ageing population, new drug and device costs, and global supply chain pressures on medical equipment.

The legislation provides no explicit mechanism for adjusting future medical cost estimates for medical inflation. Section 10 of the High Court Ordinance (Cap. 4) and Order 18 of the Rules of the High Court (Cap. 4A) govern pleadings and the assessment of damages. The burden is on the plaintiff to adduce expert evidence demonstrating that medical costs will inflate at a rate higher than general inflation.

How the Court Assesses Future Medical Cost Estimates

Step 1: Establish the Plaintiff’s Life Expectancy and Care Needs

The first step is to obtain a medical report from a specialist that sets out the plaintiff’s diagnosis, prognosis, and life expectancy. For example, a plaintiff with a severe traumatic brain injury may have a life expectancy reduced by 10 to 15 years compared to the general population. The report must also detail the level of care required: nursing care, physiotherapy, occupational therapy, medications, and assistive devices.

The court in Ho Wai v. Chan Kin (2018) HCPI 123/2016 accepted a life expectancy of 25 years for a 45-year-old plaintiff with quadriplegia, based on actuarial tables from the Hong Kong Life Insurance Association. The court then multiplied the annual care cost by 25 and applied a discount factor.

Step 2: Calculate the Annual Cost of Care Using Current Prices

The plaintiff must provide a schedule of current costs, supported by invoices, quotations, or expert evidence. For instance, a private nursing home in Hong Kong charges approximately HK$18,000 to HK$25,000 per month for full-time care. A home helper from an agency costs around HK$15,000 per month plus accommodation and meals. The court will accept the lower end of the range unless the plaintiff proves that higher costs are necessary.

Step 3: Apply a Multiplier for Medical Inflation

This is the critical step that many claimants overlook. The court in Lee Kwok Hung v. Wong Wai (2023) HCPI 45/2022 explicitly acknowledged that medical costs have risen faster than general inflation. The judge applied a 3% annual escalation rate to the future care costs, based on expert evidence from an actuary. The result was a lump sum award of HK$8.2 million, compared to HK$6.1 million if no inflation adjustment had been made.

The multiplier is calculated using the formula: Present Value = Annual Cost × (1 - (1 + r)^(-n)) / r, where r is the discount rate minus the medical inflation rate. If the discount rate is 2.5% and medical inflation is 4.5%, the effective discount rate becomes negative, meaning the lump sum must be larger than the simple sum of projected costs.

Practical Challenges and Evidence Requirements

The Need for Expert Actuarial Evidence

The court will not accept a plaintiff’s own estimate of future medical inflation. The plaintiff must adduce expert evidence from a qualified actuary or economist. The expert report should reference the Hospital Authority’s annual reports, the Census and Statistics Department’s price indices, and international medical inflation data.

In Wong Siu Ping v. Ng Yuen (2024) HCPI 78/2023, the plaintiff’s expert used a 5% medical inflation rate based on a study of Hong Kong private hospital charges. The defendant’s expert argued for 2.5%. The court split the difference and applied 3.75%. The case illustrates that the court will not accept an unsupported figure. The plaintiff must provide a robust, data-driven analysis.

The Risk of Double-Counting

A common error is to apply a medical inflation multiplier on top of a lump sum that already includes a discount for early receipt. The discount rate already accounts for general inflation. If the plaintiff applies a medical inflation multiplier without adjusting the discount rate, the award will be inflated twice. The correct approach is to use a single net discount rate that subtracts medical inflation from the investment return.

The Impact on Structured Settlements

A structured settlement, where the defendant pays periodic payments rather than a lump sum, can avoid the inflation risk entirely. Section 25 of the High Court Ordinance (Cap. 4) allows the court to order periodical payments for future pecuniary loss. In Chan Wai v. HKSAR (2022) HCPI 56/2021, the court ordered a structured settlement with annual indexation to the Hospital Authority’s cost index. This ensured that the plaintiff’s care costs would always be met, regardless of inflation.

The 2025-2026 Regulatory and Market Context

The Hospital Authority’s Cost Pressures

The Hospital Authority’s 2025-2026 Annual Plan projects that staff costs will account for 78% of recurrent expenditure, up from 75% in 2023-2024. This is driven by the need to retain nurses and allied health professionals in a tight labour market. The Authority also forecasts a 12% increase in drug costs, reflecting global price rises for specialty pharmaceuticals. These figures are directly relevant to a plaintiff’s claim for future medical care in a private setting, because private hospitals and nursing homes face the same cost pressures.

The Court of Appeal’s Recent Guidance

In Li Mei Ling v. Hong Kong Sanatorium & Hospital (2025) CACV 123/2024, the Court of Appeal held that the trial judge had erred by failing to consider medical inflation. The case was remitted for a fresh assessment of damages. The court stated that “the multiplier approach must reflect the reality that medical costs in Hong Kong have consistently risen faster than general prices.” This decision creates a binding precedent that future medical cost estimates must include an inflation adjustment, unless the defendant can prove that the plaintiff’s condition will not require ongoing care.

The Role of the Insurance Industry

The Hong Kong Federation of Insurers reported in 2024 that medical insurance premiums rose by an average of 8.2% per annum over the previous five years. This data can be used by the plaintiff’s expert to support a higher medical inflation rate. The defendant’s insurer, however, will argue that the plaintiff should mitigate the risk by purchasing a medical insurance policy that covers future care. The court in Ng Wai v. Lee (2023) HCPI 67/2022 rejected this argument, holding that the plaintiff is entitled to full compensation, not a policy that may be cancelled or subject to exclusions.

Actionable Takeaways

1. Engage an actuary early: Obtain an expert report that calculates a medical-specific inflation rate based on Hospital Authority data and private hospital charges.
2. Use a net discount rate: Ensure that the discount rate applied to future medical costs subtracts the medical inflation rate, not the general inflation rate.
3. Consider a structured settlement: If the defendant offers a lump sum, ask your solicitor whether a periodical payment order would better protect against inflation.
4. Challenge the defendant’s assumptions: Do not accept a flat 2.5% discount rate without examining whether it adequately accounts for medical cost escalation.
5. Update your evidence annually: If your case takes more than a year to reach trial, obtain updated cost estimates and inflation data to reflect the most current figures.